63 related articles for article (PubMed ID: 31789307)
1. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
2. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
3. Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis.
Chen YQ; Xu JW; Xu XF; Wang XL; Huo LQ; Wang L; Zhou GH; Gu J
Breast; 2021 Oct; 59():124-134. PubMed ID: 34229127
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
[TBL] [Abstract][Full Text] [Related]
5. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Nomogram for Prognosis Prediction in Patients with Synchronous Primary Thyroid and Breast Cancer Based on SEER Database.
Huo M; Zhang J; Hou M; Li J; Bai N; Xu R; Guo J
Cancer Invest; 2024 Mar; 42(3):212-225. PubMed ID: 38527848
[TBL] [Abstract][Full Text] [Related]
7. A Population-Based Research Utilized a Risk Stratification Model to Forecast the Overall Survival of Young Women With Diagnosed Stage IV Breast Cancer.
Tang W; Shao M; Fang W; Wang J; Fu D
Clin Breast Cancer; 2023 Dec; 23(8):e523-e533. PubMed ID: 37741796
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological Analysis and Prognosis of Conjunctival Cancer in the Past Twenty Years: A Population-Based Retrospective Study Using SEER Data.
Diao Y; Li X; Huo Y; Li Z; Yang Q; Huang Y; Wang L
Biomed Res Int; 2020; 2020():1203938. PubMed ID: 32724792
[TBL] [Abstract][Full Text] [Related]
9. Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer.
Lin HY; Bedrosian I; Babiera GV; Shaitelman SF; Kuerer HM; Woodward WA; Ueno NT; Shen Y
Cancer; 2017 Jul; 123(14):2618-2625. PubMed ID: 28295213
[TBL] [Abstract][Full Text] [Related]
10. Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.
Rueth NM; Lin HY; Bedrosian I; Shaitelman SF; Ueno NT; Shen Y; Babiera G
J Clin Oncol; 2014 Jul; 32(19):2018-24. PubMed ID: 24888808
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular mortality risk in patients with ovarian cancer: a population-based study.
Hu ZL; Yuan YX; Xia MY; Li Y; Yang Y; Wang SN; Meng XZ; Sun MY; Wang N
J Ovarian Res; 2024 Apr; 17(1):88. PubMed ID: 38664732
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of alveolar soft part sarcoma in children and adolescents: A population-based study.
Yuan X; Zhou B; Zhong J
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101852. PubMed ID: 38570254
[TBL] [Abstract][Full Text] [Related]
13. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients.
Xi G; Guo W; Kang D; Ma J; Fu F; Qiu L; Zheng L; He J; Fang N; Chen J; Li J; Zhuo S; Liao X; Tu H; Li L; Zhang Q; Wang C; Boppart SA; Chen J
Theranostics; 2021; 11(7):3229-3243. PubMed ID: 33537084
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Breast Cancer: Understanding the Patient Experience.
Whisenant MS; Alexander A; Woodward WA; Teshome M; Ueno NT; Williams LA
Cancer Nurs; 2024 Jan-Feb 01; 47(1):E65-E72. PubMed ID: 36729801
[TBL] [Abstract][Full Text] [Related]
15. Infinite mixture-of-experts model for sparse survival regression with application to breast cancer.
Raman S; Fuchs TJ; Wild PJ; Dahl E; Buhmann JM; Roth V
BMC Bioinformatics; 2010 Oct; 11 Suppl 8(Suppl 8):S8. PubMed ID: 21034433
[TBL] [Abstract][Full Text] [Related]
16. Nomograms should be noted.
Obi S; Omata M
Hepatol Int; 2024 Apr; 18(2):420-421. PubMed ID: 38424395
[No Abstract] [Full Text] [Related]
17. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of Prognostic Nomogram for Elderly Breast Cancer: A Large-Cohort Retrospective Study.
Li G; Zhang D
Int J Gen Med; 2022; 15():87-101. PubMed ID: 35018116
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer.
Yu J; Jin T; Zhang T
Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
